Skip to content

comparing the outcome of fat transplant versus platelet poor plasma biofiller in treating acne scars

Autologous nanofat transplant versus platelet poor plasma biofiller in atrophic acne scars. A simultaneous split face comparative pilot study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090193
Enrollment
30
Registered
2025-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L905- Scar conditions and fibrosis of skin

Interventions

Intervention1: platelet poor plasma biofiller: subdermal filling of platelet poor plasma on right side of face. Control Intervention1: nano fat transfer on one side of face: harvesting sub cutaneous f

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Grade II to Grade IV acne scars classified on the basis of Goodman qualitative classification. Patient with equal Goodman quantitative and qualitative scores on both halves of the face. No active acne lesions. Patients with atrophic scars only

Exclusion criteria

Exclusion criteria: Patients outside age criteria Contraindication to surgical procedure History of hypertrophic scarring or keloid Allergic reaction to lignocaine and bupivacaine. Active acne, folliculitis, herpes Pregnancy Systemic, autoimmune, bleeding disorders, patients on anticoagulant drugs and with unrealistic expectations.

Design outcomes

Primary

MeasureTime frame
1.Are PPP Bio gel and autologous nano fat transplant effective in treating atrophic acne scars? 2.Which modality has superior results Timepoint: 6 months from intervention

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactArchana Reddy Purumandla

institute of naval medicine

asunilk22@gmail.com8309033790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026